ArticleTranslational lung cancer research2023

First-line osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer: efficacy and safety during the COVID-19 pandemic.

Suganija Lakkunarajah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.